Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Saarland University

Headquarters: Saarbruken, Germany
Year Founded: 1948
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | May 10, 2023
Discovery & Translation

Integrated’s AI platform to discover senolytic compounds; plus Editas’ transgene knock-in method and more

BioCentury’s roundup of translational news
BioCentury | Feb 5, 2019
Distillery Therapeutics

Cancer

BioCentury | May 3, 2017
Distillery Therapeutics

Cancer

BioCentury | Jul 16, 2015
Distillery Therapeutics

Therapeutics: An undetermined target

BioCentury | Jul 9, 2015
Distillery Therapeutics

Therapeutics: DNA polymerase III β subunit (DnaN)

BioCentury | Oct 16, 2014
Distillery Therapeutics

Indication: Neurology

BioCentury | Jun 12, 2014
Cover Story

Nav-i-gating antibodies for pain

BioCentury | Dec 12, 2013
Distillery Therapeutics

Indication: Infectious disease

BioCentury | Aug 22, 2013
Distillery Therapeutics

Indication: Cancer

BioCentury | Jul 25, 2013
Distillery Therapeutics

Indication: Cancer

Items per page:
1 - 10 of 19